Literature DB >> 21111381

Gastrointestinal bleeding after gastric bypass surgery: nuisance or catastrophe?

Amanda Dick1, T Karl Byrne, Megan Baker, Amanda Budak, Katherine Morgan.   

Abstract

BACKGROUND: Bleeding in the early postoperative period after gastric bypass surgery is a rare complication reported in 1-4% of cases. In most cases, the bleeding will be self-limited, resolving after discontinuation of anticoagulation for deep venous thrombosis prophylaxis. Occasionally, however, bleeding can be problematic, resulting in significant postoperative morbidity or even mortality. The purpose of the present study was to review cases of early postoperative gastrointestinal bleeding after gastric bypass to identify possible risk factors and examine outcomes.
METHODS: A prospective weight loss surgery patient database was reviewed to examine the cases occurring from January 2005 to July 2008. Patients with early postoperative bleeding were identified. The demographics and co-morbidities were compared between those with and without postoperative bleeding. The outcomes of interest included the transfusion requirement, postoperative morbidity, need for reoperation, length of hospital stay, intensive care unit admission, and 30-day mortality.
RESULTS: A total of 776 patients had undergone gastric bypass during the study period. Of these, 26 (3.3%) were identified with early postoperative bleeding. No significant differences were found in the demographics between the patients with early postoperative bleed and those without. Of the patients with early postoperative bleeding, the most common presenting sign or symptom was tachycardia (46%) followed by melena (32%) and hematemesis (18%). The transfusion requirement range was 0-11 U (average 3.2 U/patient). Of the 26 patients, 4 (15%) required intensive care unit admission and 8 (31%) required reoperation. Four gastrointestinal leaks, one stomal ulceration, and one gastrogastric fistula were identified in the early postoperative bleeding group. One patient (3.8%) in the early postoperative bleeding group died. Compared with nonbleeding patients, those with early postoperative bleeding had a significantly longer hospital stay (4.8 versus 3, P <.0001) and greater mortality rate (7.1% versus .9%, P <.01).
CONCLUSION: Postoperative bleeding is a significant complication after gastric bypass surgery. Although in many cases, the bleeding will be self-limited, it can result in additional notable complications. In the present study, postoperative bleeding contributed to significantly longer hospital stays and resulted in 1 death. A patient with bleeding after gastric bypass should raise due concern, with attention to the potential attendant complications.
Copyright © 2010 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21111381     DOI: 10.1016/j.soard.2010.07.016

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  10 in total

1.  Postoperative bleeding after laparoscopic Roux en Y gastric bypass: predictors and consequences.

Authors:  Syed Nabeel Zafar; Kaylie Miller; Jessica Felton; Eric S Wise; Mark Kligman
Journal:  Surg Endosc       Date:  2018-09-19       Impact factor: 4.584

2.  Robot-assisted versus laparoscopic gastric bypass: comparison of short-term outcomes.

Authors:  Stephan R Myers; John McGuirl; Jillian Wang
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

3.  The Impact of Staple Line Reinforcement Utilization on Bleeding and Leak Rates Following Sleeve Gastrectomy for Severe Obesity: a Propensity and Case-Control Matched Analysis.

Authors:  Matthew Cunningham-Hill; Michael Mazzei; Huaqing Zhao; Xiaoning Lu; Michael A Edwards
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  Editorial: Novel Insights Into Obesity-Related Diseases.

Authors:  Xiang Zhang; Yanmin Wang; Sanyuan Hu
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

5.  Laparoscopic Roux-en-Y gastric bypass in obese Korean patients: efficacy and potential adverse events.

Authors:  Ji Yeon Park; Yong Jin Kim
Journal:  Surg Today       Date:  2015-04-26       Impact factor: 2.549

6.  [Management of complications in bariatric surgery].

Authors:  R A Weiner; C Stroh; I El-Sayes; M Frenken; S Theodoridou; O Scheffel; S Weiner
Journal:  Chirurg       Date:  2015-01       Impact factor: 0.955

7.  Anemia and the Need for Intravenous Iron Infusion after Roux-en-Y Gastric Bypass.

Authors:  Adam Kotkiewicz; Keri Donaldson; Charles Dye; Ann M Rogers; David Mauger; Lan Kong; M Elaine Eyster
Journal:  Clin Med Insights Blood Disord       Date:  2015-06-04

8.  Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity.

Authors:  Akira Sasaki; Koutaro Yokote; Takeshi Naitoh; Junji Fujikura; Karin Hayashi; Yushi Hirota; Nobuya Inagaki; Yasushi Ishigaki; Kazunori Kasama; Eri Kikkawa; Hidenori Koyama; Hiroaki Masuzaki; Takeshi Miyatsuka; Takehiro Nozaki; Wataru Ogawa; Masayuki Ohta; Shinichi Okazumi; Michio Shimabukuro; Iichiro Shimomura; Hitoshi Nishizawa; Atsuhito Saiki; Yosuke Seki; Nobuhiro Shojima; Motoyoshi Tsujino; Satoshi Ugi; Hiroaki Watada; Toshimasa Yamauchi; Takashi Yamaguchi; Kohjiro Ueki; Takashi Kadowaki; Ichiro Tatsuno
Journal:  Diabetol Int       Date:  2021-11-08

9.  Early Bleeding After Laparoscopic Roux-en-Y Gastric Bypass: Incidence, Risk Factors, and Management - a 21-Year Experience.

Authors:  Maja Odovic; Daniel Clerc; Nicolas Demartines; Michel Suter
Journal:  Obes Surg       Date:  2022-08-06       Impact factor: 3.479

10.  Morbid obesity-the new pandemic: medical and surgical management, and implications for the practicing gastroenterologist.

Authors:  John P Cello; Stanley J Rogers
Journal:  Clin Transl Gastroenterol       Date:  2013-06-06       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.